SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 127 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,712,352 | +29.9% | 1,783,701 | +1.5% | 0.00% | – |
Q1 2023 | $1,318,077 | +236538.6% | 1,757,437 | +16.2% | 0.00% | – |
Q4 2022 | $557 | -99.9% | 1,512,202 | -2.5% | 0.00% | – |
Q3 2022 | $667,000 | -50.7% | 1,551,752 | -10.6% | 0.00% | – |
Q2 2022 | $1,353,000 | -61.5% | 1,735,725 | -36.4% | 0.00% | – |
Q1 2022 | $3,518,000 | +9.8% | 2,727,532 | +8.1% | 0.00% | – |
Q4 2021 | $3,205,000 | -45.3% | 2,523,635 | -6.1% | 0.00% | -100.0% |
Q3 2021 | $5,856,000 | -41.0% | 2,686,533 | +1.5% | 0.00% | 0.0% |
Q2 2021 | $9,927,000 | +26.7% | 2,647,265 | +10.2% | 0.00% | 0.0% |
Q1 2021 | $7,834,000 | +5.1% | 2,403,244 | +9.9% | 0.00% | 0.0% |
Q4 2020 | $7,456,000 | -7.6% | 2,186,700 | +10.6% | 0.00% | -50.0% |
Q3 2020 | $8,067,000 | +42.9% | 1,977,342 | +18.4% | 0.00% | +100.0% |
Q2 2020 | $5,644,000 | +51.4% | 1,670,110 | +4.4% | 0.00% | 0.0% |
Q1 2020 | $3,728,000 | -66.8% | 1,600,076 | -48.1% | 0.00% | 0.0% |
Q4 2019 | $11,220,000 | -8.0% | 3,082,854 | +109.6% | 0.00% | -66.7% |
Q3 2019 | $12,200,000 | +0.2% | 1,470,883 | +4.1% | 0.00% | 0.0% |
Q2 2019 | $12,170,000 | -10.9% | 1,413,573 | +10.7% | 0.00% | -25.0% |
Q1 2019 | $13,653,000 | -32.5% | 1,277,261 | -44.8% | 0.00% | +33.3% |
Q4 2018 | $20,232,000 | +17.5% | 2,312,238 | +125.5% | 0.00% | -40.0% |
Q3 2018 | $17,226,000 | -15.1% | 1,025,404 | +5.9% | 0.01% | -16.7% |
Q2 2018 | $20,300,000 | +52.3% | 968,536 | +16.9% | 0.01% | +50.0% |
Q1 2018 | $13,332,000 | -13.3% | 828,643 | +2.1% | 0.00% | -20.0% |
Q4 2017 | $15,384,000 | +67.0% | 811,847 | +24.0% | 0.01% | +66.7% |
Q3 2017 | $9,211,000 | +106.9% | 654,717 | +9.6% | 0.00% | +50.0% |
Q2 2017 | $4,451,000 | +25.6% | 597,557 | +9.6% | 0.00% | +100.0% |
Q1 2017 | $3,543,000 | +55.5% | 545,118 | +6.0% | 0.00% | 0.0% |
Q4 2016 | $2,278,000 | +0.8% | 514,469 | +6.3% | 0.00% | 0.0% |
Q3 2016 | $2,259,000 | -14.1% | 483,907 | +20.9% | 0.00% | 0.0% |
Q2 2016 | $2,630,000 | +5.1% | 400,313 | +1.7% | 0.00% | 0.0% |
Q1 2016 | $2,503,000 | +6.5% | 393,699 | +0.9% | 0.00% | 0.0% |
Q4 2015 | $2,351,000 | +3.1% | 390,000 | +2.2% | 0.00% | 0.0% |
Q3 2015 | $2,281,000 | -12.0% | 381,495 | +0.6% | 0.00% | 0.0% |
Q2 2015 | $2,591,000 | +23.4% | 379,056 | +9.6% | 0.00% | 0.0% |
Q1 2015 | $2,099,000 | -8.7% | 345,957 | +4.3% | 0.00% | 0.0% |
Q4 2014 | $2,298,000 | -5.1% | 331,668 | +11.5% | 0.00% | -50.0% |
Q3 2014 | $2,421,000 | +2.2% | 297,510 | +2.1% | 0.00% | 0.0% |
Q2 2014 | $2,369,000 | +5.9% | 291,503 | +2.1% | 0.00% | 0.0% |
Q1 2014 | $2,237,000 | -8.2% | 285,424 | +3.7% | 0.00% | 0.0% |
Q4 2013 | $2,436,000 | +7.7% | 275,361 | +2.2% | 0.00% | 0.0% |
Q3 2013 | $2,261,000 | +40.1% | 269,494 | +24.5% | 0.00% | +100.0% |
Q2 2013 | $1,614,000 | – | 216,407 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |